Literature DB >> 28812579

Reproducibility and relative validity of a food frequency questionnaire to estimate intake of dietary phylloquinone and menaquinones.

S R Zwakenberg1, A I P Engelen2,3, G W Dalmeijer1, S L Booth4, C Vermeer5, J J M M Drijvers6, M C Ocke6, E J M Feskens2, Y T van der Schouw1, J W J Beulens1,7.   

Abstract

BACKGROUND/
OBJECTIVES: This study aims to investigate the reproducibility and relative validity of the Dutch food frequency questionnaire (FFQ), to estimate intake of dietary phylloquinone and menaquinones compared with 24-h dietary recalls (24HDRs) and plasma markers of vitamin K status. SUBJECTS/
METHODS: In a cross-sectional study among 63 men and 58 women, the FFQ was completed three times over a 1-year period and the reproducibility was calculated over these measurements. Twelve-monthly 24HDR were collected to estimate relative validity. In addition, the relative validity of the FFQ, compared with plasma phylloquinone and desphospho-uncarboxylated matrix Gla protein (dpucMGP), was assessed cross-sectionally among 507 postmenopausal women.
RESULTS: Intraclass correlations showed a good reproducibility, with correlations ranging from 0.65 to 0.83. The relative validity for phylloquinone intake compared with 24HDR was lower for women (rs=0.28) than men (rs=0.40). The relative validity, compared with 24HDR, for intake of short-chain menaquinones were ranging between 0.30 and 0.34. Long-chain menaquinones showed good relative validity (rs=0.60-0.69). Plasma phylloquinone concentrations were weakly correlated with phylloquinone intake (rs=0.16 (0.07-0.24). Plasma dpucMGP was negatively but weakly correlated with phylloquinone intake (rs=-0.09 (-0.18; -0.01)) and long-chain menaquinones (rs=-0.13 (-0.21; -0.04)), but not with short-chain menaquinones (rs=-0.04 (-0.13; 0.05)).
CONCLUSIONS: The FFQ is reproducible to rank subjects for phylloquinone and menaquinone intake.The relative validity of our FFQ, compared with 24HDR, to estimate intake of phylloquinone and short-chain menaquinones was low, but the relative validity for long-chain menaquinones was good. The relative validity of our FFQ, compared with plasma phylloquinone and dpucMGP, was relatively low for both phylloquinone and menaquinone intake.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28812579     DOI: 10.1038/ejcn.2017.121

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  5 in total

1.  Dramatic Decrease of Vitamin K2 Subtype Menaquinone-7 in COVID-19 Patients.

Authors:  Harald Mangge; Florian Prueller; Christine Dawczynski; Pero Curcic; Zdenka Sloup; Magdalena Holter; Markus Herrmann; Andreas Meinitzer
Journal:  Antioxidants (Basel)       Date:  2022-06-24

2.  Reproducibility and Validity of a Semi-Quantitative Food Frequency Questionnaire for Assessing Dietary Intake of Vegetarians and Omnivores in Harbin, China.

Authors:  Changbao Sun; Qingyun Wang; Cong Xu; Wan Wang; Jiage Ma; Liya Gu; Zhijing Liu; Juncai Hou; Zhanmei Jiang
Journal:  Nutrients       Date:  2022-09-24       Impact factor: 6.706

Review 3.  Perspective: Evidence before Enthusiasm-A Critical Review of the Potential Cardiovascular Benefits of Vitamin K.

Authors:  M Kyla Shea; Kathleen L Berkner; Guylaine Ferland; Xueyan Fu; Rachel M Holden; Sarah L Booth
Journal:  Adv Nutr       Date:  2021-06-01       Impact factor: 8.701

4.  The effect of menaquinone-7 supplementation on vascular calcification in patients with diabetes: a randomized, double-blind, placebo-controlled trial.

Authors:  S R Zwakenberg; P A de Jong; J W Bartstra; R van Asperen; J Westerink; H de Valk; R H J A Slart; G Luurtsema; J M Wolterink; G J de Borst; J A van Herwaarden; M A van de Ree; L J Schurgers; Y T van der Schouw; J W J Beulens
Journal:  Am J Clin Nutr       Date:  2019-10-01       Impact factor: 7.045

Review 5.  Vitamin K - sources, physiological role, kinetics, deficiency, detection, therapeutic use, and toxicity.

Authors:  Přemysl Mladěnka; Kateřina Macáková; Lenka Kujovská Krčmová; Lenka Javorská; Kristýna Mrštná; Alejandro Carazo; Michele Protti; Fernando Remião; Lucie Nováková
Journal:  Nutr Rev       Date:  2022-03-10       Impact factor: 7.110

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.